Lack of association between serum transforming growth factor-beta 1 and cancer mortality risk in a nested case-control study in Japan

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 2, 2009, Pages 273-278

  Lin, Yingsong ^a   Nakachi, Kei ^b   Ito, Yoshinori ^c   Kikuchi, Shogo ^a   Tamakoshi, Akiko ^a   Yagyu, Kiyoko ^a   Watanabe, Yoshiyuki ^d   Inaba, Yutaka ^e   Tajima, Kazuo ^f  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e JISSEN WOMEN'S UNIVERSITY   (Japan)

^f AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cancer mortality; Nested case control study; No association; TGF beta1

Indexed keywords

EID: 67650866551     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bierie B, Moses HL (2006). Tumour microenvironment: TGF-beta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer, 6, 506-20.
2. Blobe GC, Schiemann WP, Lodish HF (2000). Role of transforming growth factor beta in human disease. N Engl J Med, 342,1350-8.
3. Coupes BM, Williams S, Roberts IS, Short CD, Brenchley PE (2001). Plasma transforming growth factor beta1 and platelet activation: implications for studies in transplant recipients. Nephrol Dial Transplant, 16, 361-7.
4. Derynck R, Akhurst RJ, Balmain A (2001). TGF-beta signalling in tumor suppression and cancer progression. Nat Genet, 29, 117-29.
5. Etzioni R, Urban N, Ramsey S, et al (2003). The case for early detection. Nat Rev Cancer, 3, 243-52.
6. Grainger DJ, Heathcote K, Chiano M, et al (1999). Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet, 8, 93-7.
7. Hahn SA, Schutte M, Hoque AT, et al (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271, 350-3.
8. Ito Y, Nakachi K, Imai K, et al (2005). Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol, 15 Suppl 1, S67-73.
9. Ivanovic V, Melman A, Davis-Joseph B, et al (1995). Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer. Nat Med, 1, 282-4.
10. Markowitz S, Wang J, Myeroff L, et al (1995). Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-8.
11. Rundle AG, Vineis P, Ahsan H (2005). Design options for molecular epidemiology research within cohort studies. Cancer Epidemiol Biomarkers Prev, 14, 1899-907.
12. Siegel PM, Massagué J (2003). Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer, 3, 807-21.
13. Sidransky D (2002). Emerging molecular markers of cancer. Nat Rev Cancer, 2, 210-9.
14. Sheen-Chen SM, Chen HS, Sheen CW, Eng HL, Chen WJ (2001). Serum levels of transforming growth factor beta1 in patients with breast cancer. Arch Surg, 136, 937-40.
15. Shim KS, Kim KH, Han WS, Park EB (1999) Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. Cancer, 85, 554-61.
16. Saltzman BS, Yamamoto JF, Decker R, et al (2008). Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia. Cancer Res, 68,1236-44.
17. Tamakoshi A, Yoshimura T, Inaba Y, et al (2005). Profile of the JACC study. J Epidemiol, 15 Suppl 1, S4-8.
18. Yamaguchi K (2002). Overview of Cancer Control Programs in Japan. Jpn J Clin Oncol, 32, S22 - S31.
19. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y (2000). Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation, 101, 2783-7.